D.J. St. Germain’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-96,027
Closed -$6.15M 183
2018
Q4
$6.15M Sell
96,027
-5,518
-5% -$407K 0.73% 43
2018
Q3
$9.09M Buy
101,545
+4,712
+5% +$416K 1.02% 38
2018
Q2
$7.69M Buy
96,833
+6,338
+7% +$526K 0.92% 42
2018
Q1
$8.07M Buy
90,495
+78,911
+681% +$7.58M 1.02% 42
2017
Q4
$1.21M Buy
11,584
+2,146
+23% +$242K 0.14% 77
2017
Q3
$1.38M Buy
9,438
+461
+5% +$62.8K 0.17% 70
2017
Q2
$1.17M Buy
8,977
+518
+6% +$63.5K 0.16% 74
2017
Q1
$1.05M Sell
8,459
-20
-0.2% -$2.39K 0.15% 77
2016
Q4
$981K Buy
8,479
+808
+11% +$90K 0.13% 78
2016
Q3
$802K Buy
7,671
+99
+1% +$10.7K 0.11% 79
2016
Q2
$747K Buy
7,572
+726
+11% +$75.1K 0.1% 85
2016
Q1
$685K Buy
6,846
+2,947
+76% +$303K 0.1% 85
2015
Q4
$467K Buy
+3,899
New +$451K 0.07% 93

Other funds holding CELG

D.J. St. Germain's CELG Position: Q1 2019 in Review

D.J. St. Germain sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 96,027 shares — an estimated $6.15M sold.

D.J. St. Germain first reported a position in CELG in Q4 2015 and held it in 13 quarters. The position peaked at $9.09M in Q3 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • D.J. St. Germain reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • D.J. St. Germain sold 96,027 Celgene Corp shares in Q1 2019, an estimated $6.15M.
  • D.J. St. Germain first reported a position in Celgene Corp in Q4 2015 and held it in 13 quarters.
  • D.J. St. Germain's Celgene Corp position peaked at $9.09M in Q3 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on D.J. St. Germain's 13F filing for Q1 2019, filed 2 May 2019.